Voyager Therapeutics to Present at Investor Conferences in November

Go back to Voyager Therapeutics to Present at Investor Conferences in November

Voyager Therapeutics (VYGR) PT Lowered to $26 at Canaccord Genuity

November 15, 2017 7:50 AM EST

Canaccord Genuity lowered its price target on Voyager Therapeutics (NASDAQ: VYGR) to $26.00 (from $35.00) while maintaining a Buy rating after updating the model following recent stock offering and other updates.

VYGR expects to run overlapping Phase 2-3 pivotal trials with the first... More